Gemini Therapeutics

400 Technology Square, 10th Floor
Cambridge
Massachusetts
02139
United States

Tel: 617-401-4400

Email: info@geminitherapeutics.com

Show jobs for this employer

About Gemini Therapeutics

Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. Our therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world, we are developing a series of potentially first-in-class therapeutics.

YEAR FOUNDED:
2015

LEADERSHIP:
President and CEO, Co-Founder: James McLaughlin
Sr. VP of Process Development and Manufacturing: Scott Lauder, Ph.D.

24 articles with Gemini Therapeutics